Leucadia National Corporation »

Black Diamond Therapeutics shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2025-09-30 $86k 23k 3.79

More positions owned by Leucadia National Corporation

Spdr Gold Tr Gold Shs (GLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard World Inf Tech Etf (VGT)
Iren Ordinary Shares (IREN)
W.R. Berkley Corporation (WRB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Costco Wholesale Corporation (COST)
Eli Lilly & Co. (LLY)
Ishares Tr Russell 2000 Etf (IWM)
Pepsi (PEP)
Select Sector Spdr Tr Energy (XLE)
Cadence Design Systems (CDNS)
Chevron Corporation (CVX)
Citigroup Com New (C)
Nxp Semiconductors N V (NXPI)

View all positions for Leucadia National Corporation

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
Vestal Point Capital
NEA Management Company
Vanguard Group
Tang Capital Management
Marshall Wace
Siren
BlackRock
Arrowstreet Capital, Limited Partnership
Millennium Management
UBS Group
AWM Investment Company
Renaissance Technologies
Geode Capital Management
Northern Trust

View all funds holding Black Diamond Therapeutics